LIST OF FIGURES
• FIGURE 1 RESEARCH DESIGN........................................................................................................................................... 20
• FIGURE 2 BOTTOM-UP APPROACH.................................................................................................................................. 23
• FIGURE 3 TOP-DOWN APPROACH.................................................................................................................................... 24
• FIGURE 4 DATA TRIANGULATION...................................................................................................................................... 25
• FIGURE 5 ASSUMPTIONS FOR THE RESEARCH STUDY................................................................................................... 26
• FIGURE 6 HUMAN INSULIN MARKET SHARE, BY KEY PLAYER, 2014.............................................................................. 27
• FIGURE 7 FUTURE TRENDS: HUMAN INSULIN MARKET SIZE, BY PRODUCT( 2015 – 2020)............................................ 28
• FIGURE 8 FUTURE TRENDS: HUMAN INSULIN DRUGS MARKET SHARE, BY TYPE( 2015 VS. 2020).............................. 29
• FIGURE 9 FUTURE TRENDS: HUMAN INSULIN DRUGS MARKET SIZE, BY BRAND( 2015 – 2020).................................... 29
• FIGURE 10 FUTURE TRENDS: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE( 2015 – 2020)...................................................................................................................... 30
• FIGURE 11 FUTURE TRENDS: HUMAN INSULIN MARKET SHARE, BY REGION( 2015)...................................................... 31
• FIGURE 12 ATTRACTIVE GROWTH OPPORTUNITIES IN THE HUMAN INSULIN MARKET................................................... 32
• FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE HUMAN INSULIN MARKET IN 2015............................... 33
• FIGURE 14
NORTH AMERICA TO COMMAND THE LARGEST SHARE OF ALL SEGMENTS OF THE HUMAN INSULIN DELIVERY DEVICES MARKET IN 2015.......................................................................... 34
• FIGURE 15 LANTUS IS EXPECTED TO BE THE LEADING INSULIN ANALOG TILL 2020...................................................... 34
• FIGURE 16
CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR HUMAN INSULIN PRODUCTS DURING THE FORECAST PERIOD.................................................................................................................................... 35
• FIGURE 17 MARKET EVOLUTION OF HUMAN INSULIN PRODUCTS................................................................................... 38
• FIGURE 18 HUMAN INSULIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES................................ 39
• FIGURE 19 GROWTH IN DIABETIC PATIENT POPULATION ACROSS KEY WHO REGIONS( 2000 – 2030)............................ 40
• FIGURE 20 PROPORTION OF GERIATRIC POPULATION, BY COUNTRY( 2012 VS. 2020)................................................... 41
• FIGURE 21
• FIGURE 22
GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES( 2010 – 2012).................................................................................................................................. 44
PORTER’ S FIVE FORCES ANALYSIS( 2014): INCREASING NUMBER OF NEW PRODUCT MANUFACTURERS INCREASES MARKET COMPETITION....................................................... 53
• FIGURE 23 DELIVERY DEVICES POISED TO GROW AT THE HIGHEST RATE DURING 2015-2020...................................... 57
• FIGURE 24
U. S. & EUROPE LEAD GLOBALLY, IN TERMS OF THE NUMBER OF ONGOING HUMAN INSULIN-BASED CLINICAL STUDIES( 2015)....................................................................................... 58
• FIGURE 25 LONG-ACTING DRUGS TO LEAD THE INSULIN ANALOGS AND BIOSIMILARS MARKET TILL 2020................ 63
• FIGURE 26
ASIA-PACIFIC IS POISED TO BE THE FASTEST GROWING MARKET FOR LONG-ACTING INSULIN ANALOGS AND BIOSIMILAR PRODUCTS DURING FORECAST PERIOD............................................. 65
sales @ marketsandmarkets. com www. marketsandmarkets. com
22